Pharmaceuticals, Biotechnology and Life Sciences
Hikma Pharmaceuticals has launched Dexrazoxane for Injection, 250mg and 500mg vials, the generic equivalent to Zinecard, through its US wholly-owned subsidiary…
Boehringer Ingelheim and HealthPrize Technologies are expanding the RespiPoints digital support program to anyone taking one of several Boehringer Ingelheim…
The U.S. Food and Drug Administration has approved Ultragenyx Pharmaceutical’s Crysvita (burosumab), the first drug approved to treat adults and children ages…
Creso Pharma said Wednesday that CLV Frontier Brands Pty, its equal one-third joint venture with UK-based Baltic Beer Company and…
Sanofi has gotten an offer from Advent International, a global investor in healthcare sector, for purchase of Zentiva, Sanofi’s European…
Herantis Pharma has gotten positive results from a safety evaluation in the ongoing Phase 1 clinical study of its investigational…
Telix Pharmaceuticals, the specialist for radiopharmaceuticals or “molecularly-targeted radiation” (MTR), has entered into a research partnership with the French National…
Novartis has announced a new post hoc analysis of the pivotal Phase III heart failure study, PARADIGM-HF, which showed that…
Sanofi is investing €350 million for the construction of a new vaccine manufacturing facility at the Sanofi Pasteur Canadian headquarters…
Alexion has offered to buy shares in a Stockholm-based biopharmaceutical company Wilson Therapeutics, which develops novel therapies for patients with…